Yahoo
Shenzhen - Delayed Quote CNY

Valiant Co.,Ltd (002643.SZ)

11.58 +0.48 (+4.32%)
At close: 3:04:15 PM GMT+8
Chart Range Bar
Loading chart for 002643.SZ
  • Previous Close 11.10
  • Open 11.00
  • Bid 11.58 x --
  • Ask 11.60 x --
  • Day's Range 11.13 - 11.63
  • 52 Week Range 10.75 - 22.22
  • Volume 17,335,116
  • Avg. Volume 15,194,484
  • Market Cap (intraday) 10.606B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 42.89
  • EPS (TTM) 0.27
  • Earnings Date --
  • Forward Dividend & Yield 0.13 (1.13%)
  • 1y Target Est 19.50
  • Moby Rating Neutral

Valiant Co.,Ltd. research, develops, produces and sells chemical materials worldwide. It provides LCD, OLED, cyclohexane materials, photoresist monomer, photoacid, polymer, specialization, and polyimide monomer; and environmental protection materials, including automobile exhausts purification materials, petrochemicals, gas adsorption and separation, VOCs adsorption, flue gas denitrification, and benzene alkylation. The company also offers active pharmaceutical ingredients, pharmaceutical intermediates, pharmaceutical preparations, traditional Chinese medicine derivatives, and nutritional and health foods; life science products related to drug development, genomics, proteomics, metabonomics, food safety analysis, etc.; and diagnostic reagent products used for the diagnosis of human diseases, such as AIDS, hepatitis, cancer, dengue, fever, cardiovascular and cerebrovascular diseases, etc., as well as for the detection of drug abuse and endocrine levels. In addition, it provides electrolyte additives for lithium batteries and perovskite solar cell materials. The company was formerly known as Yantai Valiant Fine Chemicals Co., Ltd. and changed its name to Valiant Co.,Ltd. in May 2015. Valiant Co.,Ltd. was founded in 1992 and is headquartered in Yantai, China.

www.valiant-cn.com

4,887

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002643.SZ
22.08%
SSE Composite Index (000001.SS)
8.34%

1-Year Return

002643.SZ
16.63%
SSE Composite Index (000001.SS)
8.01%

3-Year Return

002643.SZ
27.06%
SSE Composite Index (000001.SS)
20.89%

5-Year Return

002643.SZ
39.58%
SSE Composite Index (000001.SS)
3.78%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 974.14M
Earnings 91.08M
Profit Margin 9.35%

Q3

FY25

Q4

FY25

Q2

FY26

Q3

FY26

0
200M
400M
600M
800M
-2.0%
0.0%
2.0%
4.0%
6.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

18.00
19.50 Average
11.58 Current
21.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.43%

  • Return on Assets (ttm)

    2.27%

  • Return on Equity (ttm)

    4.19%

  • Revenue (ttm)

    3.85B

  • Net Income Avi to Common (ttm)

    247.36M

  • Diluted EPS (ttm)

    0.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.46B

  • Total Debt/Equity (mrq)

    25.14%

  • Levered Free Cash Flow (ttm)

    83.61M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: